Literature DB >> 7151176

A single-base change at a splice site in a beta 0-thalassemic gene causes abnormal RNA splicing.

R Treisman, N J Proudfoot, M Shander, T Maniatis.   

Abstract

We have studied the structure and transcription of a cloned human beta-globin gene from a fetus diagnosed for beta 0 thalassemia. The sequence of the beta 0 gene differs from that of a normal beta-globin gene at positions 1 and 74 of the second intervening sequence (IVS2). The position 1 change alters the GT dinucleotide conserved at 5' splice sites, while the position 74 change is a common sequence polymorphism. When the cloned beta 0 gene is introduced into HeLa cells by use of an SV40-derived plasmid vector, two abnormally spliced cytoplasmic beta-globin RNAs are detected. The predominant RNA differs from normal beta-globin mRNA by the insertion of the first 47 nucleotides of IVS2 between exons 2 and 3. The less abundant RNA comprises the normal first exon spliced directly to the third. Analysis of nuclear RNA suggests that the beta 0 transcript is inefficiently spliced and that the removal of the two intervening sequences is coupled.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7151176     DOI: 10.1016/0092-8674(82)90452-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  111 in total

1.  Analysis of inhibitory action of modified U1 snRNAs on target gene expression: discrimination of two RNA targets differing by a 1 bp mismatch.

Authors:  Peng Liu; Amy Gucwa; Mary Louise Stover; Emily Buck; Alexander Lichtler; David Rowe
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

2.  Aberrant splicing of androgen receptor mRNA results in synthesis of a nonfunctional receptor protein in a patient with androgen insensitivity.

Authors:  C Ris-Stalpers; G G Kuiper; P W Faber; H U Schweikert; H C van Rooij; N D Zegers; M B Hodgins; H J Degenhart; J Trapman; A O Brinkmann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  Beta-thalassemia major resulting from a compound heterozygosity for the beta-globin gene mutation: further evidence for multiple origin and migration of the thalassemia gene.

Authors:  Y Chifu; H Nakashima; H Hara; E Yokota; T Imamura
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

4.  A 3' splice site consensus sequence mutation in the cystic fibrosis gene.

Authors:  H Guillermit; P Fanen; C Ferec
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

5.  Effect of 5' splice site mutations on splicing of the preceding intron.

Authors:  M Talerico; S M Berget
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

6.  Marked increases of two kinds of two-exon-skipped albumin mRNAs with aging and their further increase by treatment with 3'-methyl-4-dimethylaminoazobenzene in Nagase analbuminemic rats.

Authors:  T Kaneko; H Shima; H Esumi; M Ochiai; S Nagase; T Sugimura; M Nagao
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

7.  Mutation in a heterochromatin-specific chromosomal protein is associated with suppression of position-effect variegation in Drosophila melanogaster.

Authors:  J C Eissenberg; T C James; D M Foster-Hartnett; T Hartnett; V Ngan; S C Elgin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

8.  Escherichia coli DNA polymerase II is homologous to alpha-like DNA polymerases.

Authors:  H Iwasaki; Y Ishino; H Toh; A Nakata; H Shinagawa
Journal:  Mol Gen Genet       Date:  1991-04

9.  Donor splice site mutation in the apolipoprotein (Apo) C-II gene (Apo C-IIHamburg) of a patient with Apo C-II deficiency.

Authors:  S S Fojo; U Beisiegel; U Beil; K Higuchi; M Bojanovski; R E Gregg; H Greten; H B Brewer
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

10.  Expression of the Saccharomyces cerevisiae RAD50 gene during meiosis: steady-state transcript levels rise and fall while steady-state protein levels remain constant.

Authors:  W E Raymond; N Kleckner
Journal:  Mol Gen Genet       Date:  1993-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.